These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27732981)

  • 1. Validation of the Preoperative Platelet-to-Lymphocyte Ratio as a Prognostic Factor in a European Cohort of Patients with Upper Tract Urothelial Carcinoma.
    Dalpiaz O; Krieger D; Ehrlich GC; Pohlmann K; Stojakovic T; Pummer K; Zigeuner R; Pichler M; Hutterer GC
    Urol Int; 2017; 98(3):320-327. PubMed ID: 27732981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinoma.
    Hutterer GC; Sobolev N; Ehrlich GC; Gutschi T; Stojakovic T; Mannweiler S; Pummer K; Zigeuner R; Pichler M; Dalpiaz O
    J Clin Pathol; 2015 May; 68(5):351-5. PubMed ID: 25661796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.
    Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J
    Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of Platelet-Lymphocyte Ratio and Monocyte-Lymphocyte Ratio as a New Promising Prognostic Factor in Upper Tract Urothelial Carcinoma With Large Tumor Sizes > 3 cm.
    Jan HC; Hu CY; Yang WH; Ou CH
    Clin Genitourin Cancer; 2020 Aug; 18(4):e484-e500. PubMed ID: 32199741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of preoperative plasma fibrinogen level and platelet-to-lymphocyte ratio (F-PLR) in patients with localized upper tract urothelial carcinoma.
    Huang J; Yuan Y; Wang Y; Zhang J; Kong W; Chen H; Chen Y; Huang Y
    Oncotarget; 2017 May; 8(22):36761-36771. PubMed ID: 27901490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients.
    Krenn-Pilko S; Langsenlehner U; Thurner EM; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
    Br J Cancer; 2014 May; 110(10):2524-30. PubMed ID: 24675383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.
    Dalpiaz O; Ehrlich GC; Mannweiler S; Hernández JM; Gerger A; Stojakovic T; Pummer K; Zigeuner R; Pichler M; Hutterer GC
    BJU Int; 2014 Sep; 114(3):334-9. PubMed ID: 24053693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.
    Dalpiaz O; Pichler M; Mannweiler S; Martín Hernández JM; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC
    Br J Cancer; 2014 May; 110(10):2531-6. PubMed ID: 24691424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma.
    Dalpiaz O; Pichler M; Mrsic E; Reitz D; Krieger D; Venturino L; Bezan A; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC
    J Clin Pathol; 2015 Jul; 68(7):547-51. PubMed ID: 25862811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De Ritis Ratio (AST/ALT) as a Significant Prognostic Factor in Patients With Upper Tract Urothelial Cancer Treated With Surgery.
    Lee H; Choi YH; Sung HH; Han DH; Jeon HG; Chang Jeong B; Seo SI; Jeon SS; Lee HM; Choi HY
    Clin Genitourin Cancer; 2017 Jun; 15(3):e379-e385. PubMed ID: 27692696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
    Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment platelet-to-lymphocyte ratio is associated with the response to first-line chemotherapy and survival in patients with metastatic gastric cancer.
    Wang J; Qu J; Li Z; Che X; Liu J; Teng Y; Jin B; Zhao M; Liu Y; Qu X
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28238215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of preoperative systemic inflammation markers in localized upper tract urothelial cell carcinoma: a large, multicenter cohort analysis.
    Son S; Hwang EC; Jung SI; Kwon DD; Choi SH; Kwon TG; Noh JH; Kim MK; Seo IY; Kim CS; Kang SG; Cheon J; Ha HK; Jeong CW; Ku JH; Kwak C; Kim HH
    Minerva Urol Nefrol; 2018 Jun; 70(3):300-309. PubMed ID: 29381018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection.
    Espiritu PN; Sverrisson EF; Sexton WJ; Pow-Sang JM; Poch MA; Dhillon J; Spiess PE
    Urol Oncol; 2014 Jul; 32(5):619-24. PubMed ID: 24495448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the Role of the Preoperative Blood-Based Inflammation Biomarkers in the Prognosis of Upper Tract Urothelial Carcinoma With Radical Nephroureterectomy? A Single-Centre Retrospective Study.
    Luo Z; Jiao B; Huang T; Zhao H; Zhang G
    Technol Cancer Res Treat; 2022; 21():15330338221095667. PubMed ID: 35585719
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic Value of Lymphovascular Invasion in Node-Negative Upper Urinary Tract Urothelial Carcinoma Patients Undergoing Radical Nephroureterectomy.
    Liu W; Zhou Z; Dong D; Sun L; Zhang G
    Yonsei Med J; 2019 Feb; 60(2):174-181. PubMed ID: 30666839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    BJU Int; 2015 Apr; 115(4):587-94. PubMed ID: 24947340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Rink M; Sharifi N; Fritsche HM; Aziz A; Miller F; Kluth LA; Ngamsri T; Dahlem R; Chun FK; Shariat SF; Stenzl A; Fisch M; Gakis G
    J Urol; 2014 Feb; 191(2):316-22. PubMed ID: 24036235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma.
    Pang Q; Zhang LQ; Wang RT; Bi JB; Zhang JY; Qu K; Liu SS; Song SD; Xu XS; Wang ZX; Liu C
    World J Gastroenterol; 2015 Jun; 21(21):6675-83. PubMed ID: 26074706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is preoperative serum lactate dehydrogenase useful in predicting the outcomes of patients with upper tract urothelial carcinoma?
    Tan P; Chen J; Xie N; Xu H; Ai J; Xu H; Liu L; Yang L; Wei Q
    Cancer Med; 2018 Oct; 7(10):5096-5106. PubMed ID: 30151961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.